Goto M, Takei Y, Kawano S, Nagano K, Tsuji S, Masuda E, Nishimura Y, Okumura S, Kashiwagi T, Fusamoto H
First Department of Medicine, Osaka University Medical School, Japan.
Hepatology. 1994 Mar;19(3):675-81. doi: 10.1002/hep.1840190319.
Hepatic microcirculatory perturbation is observed after ischemia/reperfusion. Endothelin-1, a potent vasoconstrictive peptide, is known to modulate local circulation. This study was designed to examine whether endothelin-1 participates in the mechanism of microcirculatory disturbance and damage of the liver after ischemia/reperfusion. Ischemia in the median and left lateral lobes of the liver was induced for 60 min; it was followed by reperfusion for 24 hr. In some rats, endothelin-1 antiserum or control serum without endothelin-1-blocking activity was administered intravenously just before reperfusion. Rats were divided into three groups: an ischemia/reperfusion group that was injected with control serum, an endothelin-1 antiserum-treated group and a sham-operated group. Endothelin-1 concentrations in blood collected from the suprahepatic vena cava were measured before and after ischemia/reperfusion by use of a sandwich enzyme immunoassay. Index of blood volume in regional hepatic tissue and index of blood oxygenation in regional hepatic tissue were assessed with an organ reflectance spectrophotometry system before and at 5 min and 1, 2, and 24 hr after reperfusion. The endothelin-1 concentration in the ischemia/reperfusion group started to rise immediately at onset of reperfusion from basal values around 1 pg/ml and reached a value of 5 to 6 pg/ml 5 min after reperfusion; it was maintained at significantly high levels during the reperfusion period compared with the sham-operated group. Hepatic microcirculatory disturbance indicated by lowered index of blood volume in regional hepatic tissue and index of blood oxygenation in regional hepatic tissue levels was observed in the early phase of reperfusion in the ischemia/reperfusion group.(ABSTRACT TRUNCATED AT 250 WORDS)
缺血/再灌注后可观察到肝脏微循环紊乱。内皮素-1是一种强效血管收缩肽,已知可调节局部循环。本研究旨在探讨内皮素-1是否参与缺血/再灌注后肝脏微循环障碍及损伤的机制。在肝脏中叶和左外叶诱导缺血60分钟,随后再灌注24小时。在一些大鼠中,在再灌注前静脉注射内皮素-1抗血清或无内皮素-1阻断活性的对照血清。大鼠分为三组:注射对照血清的缺血/再灌注组、内皮素-1抗血清治疗组和假手术组。采用夹心酶免疫分析法测定缺血/再灌注前后从肝上腔静脉采集的血液中内皮素-1的浓度。在再灌注前、再灌注后5分钟、1小时、2小时和24小时,使用器官反射分光光度系统评估局部肝组织血容量指数和局部肝组织血液氧合指数。缺血/再灌注组内皮素-1浓度在再灌注开始时立即从基础值约1 pg/ml开始升高,再灌注5分钟后达到5至6 pg/ml;与假手术组相比,在再灌注期间维持在显著高水平。在缺血/再灌注组再灌注早期观察到局部肝组织血容量指数和局部肝组织血液氧合指数水平降低所表明的肝脏微循环障碍。(摘要截短至250字)